Fortis Malar [FORTISMLR] vs Indraprastha Medical [INDRAMEDCO] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Fortis Malar Hospitals Ltd. wins in 4 metrics, Indraprastha Medical Corporation Ltd. wins in 12 metrics, with 2 ties. Indraprastha Medical Corporation Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Fortis Malar Hospitals Ltd. | Indraprastha Medical Corporation Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 23.60 | 20.08 | Indraprastha Medical Corporation Ltd. |
| Price-to-Book Ratio | 3.10 | 5.57 | Fortis Malar Hospitals Ltd. |
| Debt-to-Equity Ratio | 0.00 | 4.76 | Tie |
| PEG Ratio | 0.00 | -5.81 | Tie |
| EV/EBITDA | 125.61 | 12.10 | Indraprastha Medical Corporation Ltd. |
| Profit Margin (TTM) | 9,464.38% | 12.60% | Fortis Malar Hospitals Ltd. |
| Operating Margin (TTM) | -13,260.00% | 13.64% | Indraprastha Medical Corporation Ltd. |
| EBITDA Margin (TTM) | N/A | 13.64% | N/A |
| Return on Equity | 1.30% | 26.98% | Indraprastha Medical Corporation Ltd. |
| Return on Assets (TTM) | 1.06% | 18.90% | Indraprastha Medical Corporation Ltd. |
| Free Cash Flow (TTM) | $15.44M | $1.20B | Indraprastha Medical Corporation Ltd. |
| Dividend Yield | 3.38% | 0.95% | Fortis Malar Hospitals Ltd. |
| 1-Year Return | -27.75% | -5.84% | Indraprastha Medical Corporation Ltd. |
| Price-to-Sales Ratio (TTM) | 2,230.27 | 2.53 | Indraprastha Medical Corporation Ltd. |
| Enterprise Value | $727.15M | $32.43B | Indraprastha Medical Corporation Ltd. |
| EV/Revenue Ratio | 1,514.91 | 2.23 | Indraprastha Medical Corporation Ltd. |
| Gross Profit Margin (TTM) | N/A | 37.00% | N/A |
| Revenue per Share (TTM) | $0 | $158 | Indraprastha Medical Corporation Ltd. |
| Earnings per Share (Diluted) | $2.42 | $19.94 | Indraprastha Medical Corporation Ltd. |
| Beta (Stock Volatility) | 0.06 | 0.58 | Fortis Malar Hospitals Ltd. |
Fortis Malar Hospitals Ltd. vs Indraprastha Medical Corporation Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Fortis Malar Hospitals Ltd. | 1.47% | -1.48% | -1.68% | 5.06% | -13.79% | -10.58% |
| Indraprastha Medical Corporation Ltd. | 0.38% | -0.95% | 4.95% | -1.44% | -21.11% | -14.34% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Fortis Malar Hospitals Ltd. | -27.75% | 1.14% | -21.88% | -2.09% | 50.95% | 481.35% |
| Indraprastha Medical Corporation Ltd. | -5.84% | 323.69% | 338.93% | 635.89% | 971.03% | 1,203.39% |
Performance & Financial Health Analysis: Fortis Malar Hospitals Ltd. vs Indraprastha Medical Corporation Ltd.
| Metric | FORTISMLR | INDRAMEDCO |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.08B | ₹37.31B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 12,868 | 399,153 |
| 90 Day Avg. Volume | 13,208 | 289,583 |
| Last Close | ₹53.15 | ₹385.95 |
| 52 Week Range | ₹40.75 - ₹77.00 | ₹342.00 - ₹640.85 |
| % from 52W High | -30.97% | -39.78% |
| All-Time High | ₹107.94 (Apr 22, 2024) | ₹640.85 (Nov 06, 2025) |
| % from All-Time High | -50.76% | -39.78% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | 0.14% |
| Quarterly Earnings Growth | 1.00% | 0.25% |
| Financial Health | ||
| Profit Margin (TTM) | 94.64% | 0.13% |
| Operating Margin (TTM) | -132.60% | 0.14% |
| Return on Equity (TTM) | 0.01% | 0.27% |
| Debt to Equity (MRQ) | 0.00 | 4.76 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹18.40 | ₹71.88 |
| Cash per Share (MRQ) | ₹18.35 | ₹50.31 |
| Operating Cash Flow (TTM) | ₹-10,605,000 | ₹1.78B |
| Levered Free Cash Flow (TTM) | ₹3.92M | ₹1.61B |
| Dividends | ||
| Last 12-Month Dividend Yield | 3.38% | 0.95% |
| Last 12-Month Dividend | ₹2.50 | ₹4.50 |
Valuation & Enterprise Metrics Analysis: Fortis Malar Hospitals Ltd. vs Indraprastha Medical Corporation Ltd.
| Metric | FORTISMLR (Apr 24, 2026) | INDRAMEDCO (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 23.60 | 20.08 |
| Forward P/E | N/A | 18.63 |
| PEG Ratio | 0.00 | -5.81 |
| Price to Sales (TTM) | 2,230.27 | 2.53 |
| Price to Book (MRQ) | 3.10 | 5.57 |
| Market Capitalization | ||
| Market Capitalization | ₹1.08B | ₹37.31B |
| Enterprise Value | ₹727.15M | ₹32.43B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1,514.91 | 2.23 |
| Enterprise to EBITDA | 125.61 | 12.10 |
| Risk & Other Metrics | ||
| Beta | 0.06 | 0.58 |
| Book Value per Share (MRQ) | ₹18.40 | ₹71.88 |
Financial Statements Comparison: Fortis Malar Hospitals Ltd. vs Indraprastha Medical Corporation Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | FORTISMLR (2025) | INDRAMEDCO (2025) |
|---|---|---|
| Revenue/Sales | 0 | 13.07B |
| Cost of Goods Sold | 0 | 8.53B |
| COGS % of Revenue | - | 65.3% |
| Gross Profit | 0 | 4.54B |
| Gross Margin | - | 34.7% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | -21.38M | 2.10B |
| Operating Margin | - | 16.1% |
| EBITDA | 5.79M | 2.64B |
| EBITDA Margin | - | 20.2% |
| Pre-Tax Income | 5.68M | 2.16B |
| Pre-Tax Income % of Revenue | - | 16.6% |
| Income Tax | 1.76M | 553.30M |
| Income Tax % of Revenue | - | 4.2% |
| Net Income (Profit) | 3.92M | 1.61B |
| Profit Margin | - | 12.3% |
Balance Sheet & Liquidity Metrics
| Metric | FORTISMLR (2025) | INDRAMEDCO (2025) |
|---|---|---|
| Cash & Equivalents | 2.02M | 614.80M |
| Total Current Assets | 341.12M | 4.31B |
| Total Current Assets % of Revenue | - | 33.0% |
| Total Current Liabilities | 66.23M | 1.79B |
| Total Current Liabilities % of Revenue | - | 13.7% |
| Long-Term Debt | N/A | 305.40M |
| Long-Term Debt % of Revenue | - | 2.3% |
| Total Shareholders Equity | 302.09M | 5.97B |
| Retained Earnings | 18.80M | 4.75B |
| Retained Earnings % of Revenue | - | 36.4% |
| Property, Plant & Equipment | 0 | 2.60B |
Cash Flow Statement Comparison
| Metric | FORTISMLR (2025) | INDRAMEDCO (2025) |
|---|---|---|
| Operating Cash Flow | -10.61M | 1.78B |
| Operating Cash Flow % of Revenue | - | 13.6% |
| Capital Expenditures | 0 | -363.30M |
| Free Cash Flow | 15.44M | 1.20B |
| FCF Margin | - | 9.2% |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | FORTISMLR | INDRAMEDCO |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 18.74M | 91.67M |
| Float Shares | 4.84M | 41.01M |
| % Held by Insiders | 72.19% | 55.41% |
| % Held by Institutions | 0.00% | 0.57% |
| % Held by Public | 27.81% | 44.02% |
Dividend Analysis & Yield Comparison: Fortis Malar Hospitals Ltd. vs Indraprastha Medical Corporation Ltd.
| Metric | FORTISMLR | INDRAMEDCO |
|---|---|---|
| Last 12-Month Dividend | ₹2.50 | ₹4.50 |
| Last 12-Month Dividend Yield | 3.38% | 0.95% |
| 3-Year Avg Annual Dividend | ₹14.17 | ₹4.00 |
| 3-Year Avg Dividend Yield | 26.20% | 1.26% |
| 3-Year Total Dividends | ₹42.50 | ₹12.00 |
| Ex-Dividend Date | Jul 24, 2024 | Sep 18, 2025 |